4.6 Article

Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells

Journal

ATHEROSCLEROSIS
Volume 193, Issue 2, Pages 328-334

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2006.09.016

Keywords

atherosclerosis; short-term high glucose; monocyte adhesion; monocyte migration; HAEC; vascular cell adhesion molecule (VCAM-1); monocyte; chemoattractant protein (MCP-1); reactive oxygen species; nuclear factor (NF)-kappa B

Ask authors/readers for more resources

Acute, short-term hyperglycemia is becoming recognized as an important risk factor for several diseases. In the present study, using human aortic endothelial cells (HAECs), we investigated whether short-term high glucose exposure, either on the scale of hours, could enhance the monocyte adhesion and migration to the subendothelium via increasing expression of adhesion molecules and release of chemotactic factors. HAECs stimulated with 25 mM D(+)glucose (HG) for not more than 12 h, exhibited rapid up-regulation of vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP- 1) mRNA and protein. Although intercellular adhesion molecule-1 (ICAM- 1) is considered as a marker of the activation of the atherogenic process, early up-regulation was not observed, and VCAM- I and MCP- I protein enhance was sufficient to increase the adhesiveness of human monocytes U-937 to HAECs and their transmigration into the subendothelial space after 4 h HG stimulation; both effects were prevented by interfering with monoclonal antibodies against VCAM- 1, CD 11b, and MCP- 1. An increased intracellular oxidative stress, a translocation of NF-kappa B to the nucleus and a prevention of adhesion and transmigration of U-937 by interfering with NF-kappa B inhibitors was also observed after a short HG treatment. Taken together, these results suggest that either acute hyperglycemic spikes could exert an influence on the onset of diabetic complications and on the development of the atherogenic profile on diabetic and non-diabetic subjects. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available